World Heart Inc

Endorse Company

WorldHeart is developing the MiFlow™ VAD: a minimally invasive, magnetically levitated miniature rotary blood pump designed to address significant issues of current VADs – including stroke, bleeding, device failures and invasiveness of implantation. VADs are mechanical devices that are surgically implanted to support a patient's own heart by pumping a portion of the cardiac output.WorldHeart believes that the MiFlow™ VAD is designed not only to be a minimally invasive alternative for providing long-term circulatory support for early-stage heart failure, but also designed to have improved blood-handling characteristics.